PPB Pharmacist Exam

No. This is an independent study page. It is not affiliated with or endorsed by the Board and contains no official questions. For authoritative information on the exam, eligibility, scheduling and results, use the Board's own website and its Students section, which lists Exams, Licensing, and Registration and Enrollment. Always verify details at source before you rely on them.

The Board publishes eight Regulatory Functions that frame its work: Registration and Marketing Authorisation (MA); Licensing, Good Pharmacy Practice, Training and CPD; Regulatory Inspections; Clinical Trials; Market Surveillance and Control; Vigilance; Quality Control (Lab and Lot Release); and Online Systems. It also lists the products it regulates, from medicines and vaccines to devices, cosmetics and herbal medicines. Build revision around these published areas rather than rumours.

We do not state a question count or duration, because the Board's published pages we reviewed do not announce them. Treat any figure you see elsewhere as unverified until the Board confirms it. Plan your practice sessions around timed blocks you set yourself, and check the official Students – Exams page for the confirmed structure before exam day.

We cannot confirm the official format from the Board's published pages. Multiple-choice practice is a reasonable study assumption because it tests recall of regulatory definitions and processes efficiently, but do not treat that as confirmed. Read the official exam instructions carefully on the day and adapt; the underlying knowledge of regulatory functions and regulated products transfers across formats.

The common failure mode is studying clinical pharmacy only and ignoring the regulatory framework. Candidates stumble on the distinction between closely related functions, such as marketing authorisation versus premises and practice licensing, or market surveillance versus vigilance. Another trap is memorising portal names without knowing what each portal handles. Learn the definitions precisely; the Board's own wording for terms such as self-medication is a good model for the precision expected.

The Board's published pages we reviewed do not state a retake policy, so we cannot give a number of attempts, a waiting period or a fee. Ask the Board directly using its published contacts before you plan a resit. Do not budget or schedule around an assumed retake rule; confirm it in writing so you know the timeline and any conditions attached.

Start with the two foundation areas: Registration and Marketing Authorisation, and Licensing with Good Pharmacy Practice and CPD. These underpin inspections and market surveillance. Then move to Clinical Trials and Vigilance, which share reporting concepts, followed by Quality Control and Lot Release. Finish with Online Systems, mapping each named portal to its function so you can answer practical process questions confidently.

The Board publishes a portal for adverse events and poor quality medicines, and a separate complaints submission link. Learning these routes is useful exam knowledge as well as good practice: vigilance reporting and complaints handling are distinct processes. Note the difference between a safety report about a product and a complaint about a service or premises, and know which route each takes.

Use the Board's website: its newsroom, safety communication and recalls, rapid alerts, downloads, and guidance documents sections. The Board also lists contact details, including a general information email and a separate address for website and portal issues, plus a telephone line. Check these before relying on any third-party summary, including this page.